feed,title,long_url,short_url
Benzinga,AlloVir's Posoleucel Shows Early Safety In Kidney Transplant Recipients,https://benzinga.com/general/biotech/22/06/27592577/allovirs-posoleucel-shows-early-safety-in-kidney-transplant-recipients,https://bit.ly/3movSyR
